ArticleBMJ open2013
Methods used to conduct and report Bayesian mixed treatment comparisons published in the medical literature: a systematic review.
Article in BMJ open, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Comparison of the Effectiveness of Various Drug Interventions to Prevent Etomidate-Induced Myoclonus: A Bayesian Network Meta-Analysis.Frontiers in medicine · 2022Pooled it
- An assessment of the methodological quality of published network meta-analyses: a systematic review.PloS one · 2015Pooled it
- Reporting of results from network meta-analyses: methodological systematic review.BMJ (Clinical research ed.) · 2014Pooled it
- Bibliometric Analysis of Surgical Articles Using Bayesian Statistics.Annals of surgery open : perspectives of surgical history, education, and clinical approaches · 2025Review
- The reporting quality and transparency of orthopaedic studies using Bayesian analysis requires improvement: A systematic review.Contemporary clinical trials communications · 2023Review
- Challenges of modelling approaches for network meta-analysis of time-to-event outcomes in the presence of non-proportional hazards to aid decision making: Application to a melanoma network.Statistical methods in medical research · 2022Article
- Bayesian Analysis Reporting Guidelines.Nature human behaviour · 2021Review
- Haematological adverse events associated with tyrosine kinase inhibitors in chronic myeloid leukaemia: A network meta-analysis.British journal of clinical pharmacology · 2019Review
- Bayesian one-step IPD network meta-analysis of time-to-event data using Royston-Parmar models.Research synthesis methods · 2017Article
- A scoping review of indirect comparison methods and applications using individual patient data.BMC medical research methodology · 2016Article
- Cardiovascular safety of new oral anticoagulants: re-analysis of 27 randomized trials based on Bayesian network meta-analysis.British journal of clinical pharmacology · 2015Article
- Gastrointestinal and renal side effects of bisphosphonates: differentiating between no proof of difference and proof of no difference.Journal of endocrinological investigation · 2015Article
- Simultaneous Comparison of Efficacy and Tolerability of Second-Generation Antipsychotics in Schizophrenia: Mixed-Treatment Comparison Analysis Based on Head-to-Head Trial Data.Psychiatry investigation · 2015Article
- [Basic concepts for network meta-analysis].Atencion primaria · 2014Article
- The quality of reporting methods and results in network meta-analyses: an overview of reviews and suggestions for improvement.PloS one · 2014Article
- Characteristics of networks of interventions: a description of a database of 186 published networks.PloS one · 2014Article
- Network meta-analysis: a technique to gather evidence from direct and indirect comparisons.Pharmacy practiceArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo identify published closed-loop Bayesian mixed treatment comparisons (MTCs) and to summarise characteristics regarding their conduct and reporting.
designSystematic review.
methodsWe searched multiple bibliographic databases (January 2006-31 July 2011) for full-text, English language publications of Bayesian MTCs comparing the effectiveness or safety of ≥3 interventions based on randomised controlled trials and having at least one closed loop. Methodological and reporting characteristics of MTCs were extracted in duplicate and summarised descriptively.
resultsWe identified 34 Bayesian MTCs spanning 13 clinical areas. Publication of MTCs increased over the 5-year period; with 76.5% published during or after 2009. MTCs included a mean (±SD) of 35.9±30.1 trials (n=33 459±71 233 participants) and 8.5±4.3 interventions (85.7% pharmacological). Non-informative and informative prior distributions were reported to be used in 44.1% and 8.8% of MTCs, respectively, with the remainder failing to specify the prior used. A random-effects model was used to analyse the networks of trials in 58.5% of MTCs, all using WinBUGS; however, code was infrequently provided (20.6%). More than two-thirds of MTCs (76.5%) also conducted traditional meta-analysis. Methods used to evaluate convergence, heterogeneity and inconsistency were infrequently reported, but from those providing detail, methods appeared varied. MTCs most often used a binary effect measure (85.3%) and ranking of interventions based on probability was common (61.8%), although rarely displayed in a figure (8.8% of MTCs). MTCs were published in 24 different journals with a mean impact factor of 9.20±8.71. While 70.8% of journals imposed limits on word counts and 45.8% limits on the number of tables/figures, online supplements/appendices were allowed in 79.2% of journals. Publication of closed-loop Bayesian MTCs is increasing in frequency, but details regarding their methodology are often poorly described. Efforts in clarifying the appropriate methods and reporting of Bayesian MTCs should be of priority.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.